Archives

Preliminary evaluation of Lithium as a GSK-3 inhibitor in MCI

12 September 2016

Lithium is a naturally occurring element and is present in very low levels in our environment including our drinking water. As a medicine it has been used for many years as a highly effective treatment for disorders of mood but more recently it has been found to exert some effects which may be beneficial to […]

The ‘EARLY’ Study

16 August 2016

Introduction by Dr Pearson on The ‘EARLY’ Study Alzheimer’s disease (AD) is a neurodegenerative disease that causes increasing damage to the nerves in the brain with symptoms, referred to as cognitive decline, such as difficulty making decisions, memory loss, and behavioural problems such as anxiety. Specific protein fragments (Amyloid-beta), which are sometimes linked with nerve […]

The ENGAGE study

19 July 2016

The latest clinical trial to be added to Join Dementia Research is ENGAGE, from Biogen Inc. Part of an international study, it is looking to determine whether a new medication called Aducanumab, can slow progression of early Alzheimer’s disease, as well as investigating whether it’s safe to use in patients. Researchers are looking for volunteers […]

The DARet Study

11 July 2016

Sometimes patients treated for Parkinson’s disease can have problems with memory and learning. This is thought to be due to a decrease in their dopamine levels due to their disease. Dopamine is a naturally occurring chemical in the brain. Patients with Parkinson’s disease are given many drugs to increase their dopamine levels back to normal, […]

INMiND-02 Study

6 June 2016

The INMiND-02 Study is a new trial looking at whether a drug that is currently used to treat arthritis could help the memory function of people with Mild Cognitive Impairment (MCI). What are the main aims of the INMiND-02 study? To see if a drug (Etanercept) already used for the treatment of rheumatoid arthritis might […]

MINDSET Study

19 May 2016

The MINDSET Study, sponsored by Axovant Sciences Ltd., is a new study looking at whether an innovatory new drug could be used to help improve the everyday lives of mild-to-moderate Alzheimer’s patients. What are the main aims? The purpose of this study is to understand whether an investigational drug known as ‘RVT 101’ improves Alzheimer’s […]

The ‘PREVENT’ Study

26 February 2016

This study is looking at the prevention of dementia through environmental intervention, and is based at Imperial College London. Aims of the Study In recent years it has been recognised that dementia is probably a very late consequence of Alzheimer’s disease, or other neurodegenerative diseases, which may have been present in people for up to 20 or […]

Can brain training and electrical brain stimulation improve cognitive functions?

14 December 2015

Cognitive functions decline with advancing age, specifically so-called executive functions, which are higher cognitive functions that include working memory, inhibition, and cognitive flexibility. The Healthy Ageing study is looking for healthy volunteers over the age of 60 without a dementia diagnosis to investigate whether training of these functions in combination with electrical brain stimulation can […]

1 2
get_header(); ?>

Archives

1 2